MENU

Speakers


  • Moderator: Sue Beruti, MD, MHA

    Moderator: Sue Beruti, MD, MHA

    Sr. Medical Director, Clinical Genomics Illumina

  • Carlo Bifulco, MD

    Carlo Bifulco, MD

    Director of Molecular Pathology and Pathology Informatics Providence St. Joseph Health

  • Jeff Conroy

    Jeff Conroy

    Chief Scientific Officer and Director Genomics Technologies OmniSeq Inc., Roswell Park Comprehensive Cancer Center

  • Brian Piening, PhD

    Brian Piening, PhD

    Associate Member at Earle A. Chiles Research Institute Technical Director Clinical Genomics at Providence St. Joseph Health

  • Alison Roos, PhD

    Alison Roos, PhD

    Associate Director Medical Affairs, Illumina

  • Nikoletta Sidiropoulos, MD

    Nikoletta Sidiropoulos, MD

    Associate Professor & Director Molecular Pathology University of Vermont Larner College of Medicine

  • Jeremy Wallentine, MD

    Jeremy Wallentine, MD

    Pathologist Intermountain Health

JUN 18, 2024

The Power of Comprehensive Genomic Profiling Testing

This virtual event welcomes clinicians, pathologists, and lab directors interested in investigating the many benefits of Comprehensive Genomic Profiling (CGP) Testing! Tissue stewardship, testing consolidation, and ability to assess current and emerging biomarkers, are one of many advantages of CGP testing implementation. One biopsy, one test, one report can lead to improved patient outcomes. 

This 4-hr event, occurring on Tuesday, June 18th, features presentations from leading pathologists and genomic specialists. Presentations will highlight a broad range of topics empowering broader access to precision oncology, including the driving advances of CGP throughout institutions in addition to real-world evidence that demonstrates the clinical utility in both academic and community oncology practices.

Attend this event and you will have the opportunity to:

  • Learn how clinicians at the forefront of their field are leveraging existing technologies and developing new methods to identify the most appropriate therapy decisions to improve patient outcomes

  • Network with likeminded individuals and potential collaborators

  • Understand the benefits of Illumina technology throughout the cancer patient journey 

  • Explore a virtual exhibit where you will find a broad range of education content, Illumina application information, and peer-reviewed publications highlighting evidence on the utility of genomics in oncology testing


Speakers
  • Moderator: Sue Beruti, MD, MHA

    Sr. Medical Director, Clinical Genomics Illumina
  • Carlo Bifulco, MD

    Director of Molecular Pathology and Pathology Informatics Providence St. Joseph Health
  • Jeff Conroy

    Chief Scientific Officer and Director Genomics Technologies OmniSeq Inc., Roswell Park Comprehensive Cancer Center
  • Brian Piening, PhD

    Associate Member at Earle A. Chiles Research Institute Technical Director Clinical Genomics at Providence St. Joseph Health
  • Alison Roos, PhD

    Associate Director Medical Affairs, Illumina
  • Nikoletta Sidiropoulos, MD

    Associate Professor & Director Molecular Pathology University of Vermont Larner College of Medicine
  • Jeremy Wallentine, MD

    Pathologist Intermountain Health

You May Also Like

Agenda

  • JUN 18, 2024

    Implementing CGP + HRD testing in-house in a large US Healthcare System

    Carlo Bifulco, MD
    Director of Molecular Pathology and Pathology Informatics Providence St. Joseph Health
    Brian Piening, PhD
    Associate Member at Earle A. Chiles Research Institute Technical Director Clinical Genomics at Providence St. Joseph Health
  • Comprehensive Genomic Profiling from Liquid Biopsy Samples
    JUN 18, 2024

    Comprehensive Genomic Profiling from Liquid Biopsy Samples

    Alison Roos, PhD
    Associate Director Medical Affairs, Illumina
  • JUN 18, 2024

    Flexible Capabilities to Enable Comprehensive Genomic Profiling

    Moderator: Sue Beruti, MD, MHA
    Sr. Medical Director, Clinical Genomics Illumina
    Nikoletta Sidiropoulos, MD
    Associate Professor & Director Molecular Pathology University of Vermont Larner College of Medicine
    Jeff Conroy
    Chief Scientific Officer and Director Genomics Technologies OmniSeq Inc., Roswell Park Comprehensive Cancer Center
    Jeremy Wallentine, MD
    Pathologist Intermountain Health
Help

Loading Comments...
Resources